Meeting
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
Authors
Alexander E. Drilon
Memorial Sloan Kettering Cancer Center, New York, NY
Alexander E. Drilon , Lu Wang , Maria E. Arcila , Eun Jung Cho , Sohail Balasubramanian , Joel R. Greenbowe , Jeffrey S. Ross , Phil Stephens , Doron Lipson , Vincent A. Miller , Mark G. Kris , Marc Ladanyi , Naiyer A. Rizvi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Lung Cancer - Non-small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 8029)
DOI
10.1200/jco.2014.32.15_suppl.8029
Abstract #
8029
Poster Bd #
44
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.
First Author: Takehito Shukuya
Poster
2015 ASCO Annual Meeting
Migration to next-generation sequencing and the identification of RET and ROS1 rearrangements plus PTEN and MET protein expression in tumor specimens from patients with lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC 2.0).
First Author: Mark G. Kris
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2018 ASCO Annual Meeting
Contribution of nationwide genome screening in Japan (LC-SCRUM-Japan) to the development of precision medicine for non-small cell lung cancer.
First Author: Takashi Seto